| Target Price | ¥550.80 |
| Price | ¥536.00 |
| Potential | |
| Number of Estimates | 8 |
| 8 Analysts have issued a price target Jcr Pharmaceuticals Co.,ltd. 2027 . The average Jcr Pharmaceuticals Co.,ltd. target price is ¥550.80. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 11 analysts: 4 Analysts recommend Jcr Pharmaceuticals Co.,ltd. to buy, 7 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Jcr Pharmaceuticals Co.,ltd. stock has an average upside potential 2027 of . Most analysts recommend the Jcr Pharmaceuticals Co.,ltd. stock at Hold. |
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
8 Analysts have issued a sales forecast Jcr Pharmaceuticals Co.,ltd. 2027 . The average Jcr Pharmaceuticals Co.,ltd. sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
8 Jcr Pharmaceuticals Co.,ltd. Analysts have issued a net profit forecast 2027. The average Jcr Pharmaceuticals Co.,ltd. net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
8 Analysts have issued a Jcr Pharmaceuticals Co.,ltd. forecast for earnings per share. The average Jcr Pharmaceuticals Co.,ltd. EPS is
. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Jcr Pharmaceuticals Co.,ltd....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


